South Africa drops probe of J&J after it agrees to lower price of TB drug and withdraws patent

​The South African Competition Commission in a statement on July 5 said it decided not to prosecute a complaint against J&J regarding "allegations of abuse of dominance," which was prompted after J&J and its subsidiary filed a secondary patent for bedaquiline last year, used to treat drug-resistant TB.

from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/0rKzp27